OBJECTIVE: To investigate the effect of moderate weight loss in older overweight subjects with angina pectoris on plasma dehydroepiandosterone sulphate (DHEAS), urinary steroid metabolites, insulin and plasma lipid concentrations. DESIGN: Single stranded study of dietitian led dietary intervention for weight loss in a volunteer outpatient group of 41 subjects with angina (22 
Introduction
Intentional weight loss in the overweight offers real bene®ts in terms of mortality 1 and morbidity. 2 The effects of weight loss in older subjects with established ischaemic disease and elevated coronary risk have been less rigorously examined, although Williamson et al, 1 suggest reduced bene®t in people with pre-existing obesity related disorders.
DHEAS has been postulated as the possible link between hyperinsulinaemia and obesity. 3 Recent evidence suggests that DHEAS exerts multiple antiatherogenic effects and that hyperinsulinaemia may reduce serum DHEAS by decreasing production and enhancing clearance. Lower DHEAS is found in those with elevated coronary risk and the overweight.
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Male survivors of myocardial infarction have also been shown to have reduced serum DHEAS in comparison with healthy matched controls. 6, 7 In women, however, a prospective study failed to ®nd any relationship between DHEAS concentrations and ischaemic heart disease (IHD). 8 Experimentally induced hyperinsulinaemia lowers DHEAS concentrations 5 and weight loss decreases plasma insulin concentrations. 9 A reduction in weight may result in a decrease in insulin and therefore an increase in DHEAS, so contributing the ultimate reduction in IHD risk. Substantial weight loss (13.0 s.d. 4.0 kg), achieved with a low energy weight reducing diet, in healthy premenopausal women and men signi®cantly increases DHEAS concentrations. 10 As far as we are aware no study has examined if this potentially bene®cial effect occurs in an older group, who will largely as a consequence of age, have lower circulating DHEAS concentrations.
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Subjects and methods
Fifty four overweight angina subjects (31 males) with a BMI (weight/height 2 ) b 26 kg/m 2 who had received a medical diagnosis of angina pectoris were recruited, and angina was con®rmed with a positive Rose questionnaire. 13 All subjects described at least one period of slimming in the preceding 2 y period before commencing the study. However, no subject had reduced his/her weight by greater than 3 kg during the three month period prior to recruitment.
Each subject attended the University of Glasgow Department of Human Nutrition on ®ve occasions over a 12 week study period. Body weight was measured on calibrated scales in kg and height was measured in metres using a stadiometer 14 and BMI calculated. Body fat distribution was evaluated from the waist, and from the ratio between waist and hip circumferences (WHR). 15 Waist and hip circumferences and triceps, biceps, suprailiac, supscapular skinfolds were measured according to the methods of Durnin and Womersley 16 and of Lean et al 17 and used to estimate body fat as a percentage of body weight. All anthropometric measurements were made in duplicate using standard methodology and mean values used for analyses.
Ethical approval for the study was obtained from the Glasgow Royal In®rmary Joint Ethics Committee, and signed informed consent was secured from all participants.
Dietary intervention
Dietary intervention used an individual dietary prescription based on the indirect measurement of resting energy expenditure (REE), measured using an indirect ventilated hood calorimeter, calibrated four weekly by alcohol burning. 18 The REE measurement was used as the subjects in the present study were elderly, with angina pectoris, and inappropriate to the standard equations designed for healthy younger subjects. None of the subjects were able to engage in physical activity so an activity factor of BMR 6 1.3 was used to estimate daily energy requirements. 19 A 2510 kJ (600 kcal) daily energy de®cit was applied and the resulting dietary prescription adjusted to the nearest 418 kJ (100 kcal) with a minimum daily prescription of 5021 kJ (1200 kcal).
The prescribed dietary composition was designed to provide greater than 50% energy from carbohydrate, less than 35% energy from fat and under 20% from protein. Total fat energy targets were divided into approximately 10% energy from each of monounsaturated, polyunsaturated and saturated fatty acids respectively and into three daily meals. Advice was given to restrict or avoid alcohol. Food distribution was designed individually using an exchanges system with 100 kcal increments and divisions into food rich in carbohydrate, protein and advice included a minimum daily intake of ®ve portions of fresh fruit and vegetables.
Monitoring of dietary intake
Dietary intake was monitored by the subjects completion of 7 d weighed food intake diaries during the week before dietary intervention and week 1, week 5 and week 12 of the intervention period, although the most important and last monitoring periods only are reported here. The ®nal recording day on each occasion was before the last study visit. The dietary records included the weights of individual food items and where possible nutritional information and portion size details of an pre-pared convenience meals. Seven days were used for recording in order to achieve the best record of dietary patterns prior to intervention, and as an aid towards compliance during intervention. 20 Standard portion weights 21 designed for the general population were applied to unweighed foods, for example, meals eaten outside the home. However, the subjects were asked to describe the unweighed portions in terms of household measures in order the increase the accuracy of these portion weight estimations. Food scales (Selectronic 2200, Salter, UK) capable of weighing up to 1000 g with 1 g intervals and a tare facility were used. To maximise the accuracy of dietary recording 22 all subjects were asked to demonstrate use of scales and were shown an example of a completed food diary.
Dietary analysis
Dietary analysis used the Compeat 4.0 system (Lifesystems, London) based on McCance and Widdowson's composition of food tables. 23 
Blood sampling and preparation
Fasting blood was sampled before (week 0) and after (week 12) dietary intervention between the hours of 9±11 am following a minimum supine rest of 5 min. Alcohol consumption was forbidden in the preceding 24 h period. Blood for DHEAS and insulin measures was drawn from the anticubital vein with a minimum of stasis using a sterile butter¯y needle and plastic syringe. Blood was anti-coagulated with lithium heparin and placed immediately on ice before centrifugation at 3000G for 20 min at 4 C and frozen at À70 C. Serum for DHEAS measurements was collected by centrifugation of clotted blood. Aliquots were pipetted into glass tubes, capped and stored at À70 C for later analysis.
Assays
Total serum concentrations of DHEAS were determined using radioimmunoassay kit (ICN Biomedicals). The assay had a working range of 0.3± 17.8 mmol/l DHEAS. Inter-and intra-assay coef®-cients of variation were 15% and 10%. Insulin measurements were carried out using immunradiometric assay with inter-and intra-assay coef®cients of variation 10% and 6% respectively and sensitivity 0.5 mU/ l/. EDTA anticoagulated blood (10 ml) was used for lipoprotein and triglyceride analyses. Triglycerides and total cholesterol were measured on an automated analysis system (Boehringer Mannheim Lewes, Sussex). High density lipoprotein cholesterol (HDL) was measured using b-quanti®cation and ultracentrifugation with the removal of low density lipoprotein cholesterol (LDL) by precipitation with heparin and manganous chloride. Twenty-four hour urine collections were made for urinary steroid metabolite analysis which were performed at 10 aliquots. The gas chromatography/mass spectrometry method used was based on that of Shackleton 24 using a Fisons MD 800 GC mass spec-trometer. The inter-and intra-assay coef®cients of variation were`15% and`10% respectively for all of the urinary steroids measured. Androgen [aetiocholanolone and androsterone] and glucocorticoid metabolites, [tetrahydrocortisol (THF), tetrahydrocortisone (THE) and 5 alpha tetrahydrocortisol (allo-THF)], were quanti®ed. Each set of pre-and post-treatment measurements for each steroid metabolite were assayed in the same batch.
Statistical methods
The biological data were normally distributed as determined from a distribution plot and were analysed using paired Student's t±tests. Using weight loss as a variable subjects were strati®ed into tertiles according to the weight loss achieved in order to see if a larger weight loss was associated with changes in androgens in plasma and urine. The dietary data showed a skewed distribution and were analysed using a paired Wilcoxon test. Pearson's correlation analysis was carried out to investigate any relationships between changes in body weight, or BMI and DHEAS, insulin and plasma lipid measurements. Linear regression analysis was used to look for any predictors of weight loss within the subject group.
Results
Thirteen patients failed to complete the protocol (9 males, 4 females). Data describing the characteristics of the 41 subjects (21 male) who completed the study are described in Table 1 . There are no signi®cant differences between the sexes for age (P 0.76) though males were signi®cantly heavier than females (3.5 s.d. 4.7 vs 27.4 s.d. 2.9 kg/m 2 (P 0.013). Percentage body fat was signi®cantly higher in females than males (P 0.0001).
At baseline no signi®cant differences were seen in biochemical measurements between males and females so the subjects were analysed as a single group. A signi®cant relationship was seen between age and DHEAS (Figure 1a) . No signi®cant associations between eight BMI or percentage body fat were observed for baseline DHEAS, principal urinary steroid metabolites or plasma insulin (Figure 1b) . Signi®cant differences were seen in total urinary THF, allo-THF, and THE for the two upper weight loss tertiles (Table 2a) but no signi®cant differences were seen in any of the other measures. Hormone changes were compared between tertiles of weight loss (Table  2b ). Weight loss tertiles 1 and 3 showed signi®cant differences for androsterone and aetiocholanolone, and the sum of these two metabolites. A signi®cant fall was seen between tertile 2 and tertile 3 for allo-THF. HDL cholesterol was negatively associated with BMI and urinary THE and the sum total of THE. THF and allo-THF was positively associated with BMI (Table 3) .
For all subjects a negative association was found between insulin and urinary tetrahydrocortisol (THF) before intervention (P 0.016).
Effects of weight loss
Mean weight change over 12 weeks was identical at 3.3 kg in men and women though when expressed as tertiles a spread of moderate weight losses was seen. Reported dietary intakes fell signi®cantly for energy and percentage energy provided by each of the macronutrients for all subjects (Table 4) .
Plasma cholesterol and HDL cholesterol fell signi®cantly (Table 1) , but amongst all other biochemical measurements there were no signi®cant changes for this whole group between baseline and 12 weeks or when expressed as tertiles of weight loss. There was a signi®cant fall in plasma insulin in women (13.1±9.7 m/U/l, P 0.023). After intervention there was no associations with changes in BMI and changes in plasma and metabolites (Table 3) .
The data were examined for correlations between weight change and change in waist circumference, changes in biochemical measures over the course of the study, and no signi®cant relationships were found. In particular, there was no associations between changes in insulin and DHEAS. Linear regression analysis failed to identify any predictors of weight loss. 
Discussion
The weight loss achieved in our study decreased lipid fractions in line with those expected 25 but failed to in¯uence any of the other biochemical measurements. Two reports have suggested a reduction in serum DHEAS concentrations with weight loss in the overweight, 10, 26 but both recruited younger subjects who were free of cardiovascular disease.
Leenen et al 10 used a 4.2 mJ/1000 kcal dietary plan in overweight premenopausal women and men aged below 51 y. These subjects had a higher BMI than our subjects (range 28±38 kg/m 2 ) and a 14% weight loss (12±13 kg) resulted in acute increases in DHEAS concentrations of 36% and 32% in women and men and a corresponding 45% and a 35% reduction in insulin concentrations in women and men respectively. Crane et al 26 achieved 5.8% weight loss in hyperinsulinaemic premenopausal hirsute women using a conventional dietary approach of 1500 kcal daily. This increased their DHEAS by 15±20% and decreased their insulin by 15±20%.
The older subjects in the present study were probably approaching their lowest adrenal androgen production rate. 27 The ability of older persons to increase or alter their steroid hormone production rate or their metabolic clearance rate (MCR) is uncertain. 28 The Obesity and DHEAS CR Hankey et al failure of DHEAS concentrations to increase during weight loss in this present study may alternatively re¯ect mechanisms in the presence of ischaemic disease. This is in line with Williamson et al 1 who found that intentional weight loss had a greater effect on IHD mortality reduction in healthy people than in those with pre-existing obesity related disease which included some symptoms of IHD.
In males high DHEAS concentrations have been related to central fat distribution and inversely with BMI insulin levels. 29 A signi®cant inverse correlation was found between BMI and DHEAS in a study of premenopausal women but with very high BMI (41.8 s.d. 10.3). 30 We failed to show either of these relationships between DHEAS and insulin, or between plasma insulin and DHEAS concentrations and body fat percentage before intervention. The lack of association between changes in insulin and changes in DHEAS are contrary to other results 10, 26 and may re¯ect the rather modest degree of overweight on our subjects, and the fact that they were not selected on the basis of hyperinsulinaemia. This is despite our care in providing an accurate dietary prescription derived using measured REE.
From theoretical considerations a lower fat intake could enhance insulin sensitivity thus increase DHEAS, especially in older subjects. 31 However, a mixed omnivorous diet has been shown to have no important in¯uence on DHEAS in comparison with a vegetarian diet 32 so it does not seem likely that the relatively low fat intake achieved in the present study (30% vs 34% energy) had a major effect. It had been anticipated that we would alter circulating DHEAS and insulin during this study, as a group or as tertiles according to weight loss. To gain a greater insight into how any change might be effected we measured urinary steroid metabolites. Insulin is known to increase conjugation of androgens. 33 We were only able to detect slight changes in various androgen and glucocorticoid metabolites during dietary intervention. The principal urinary excretion of steroid metabolites (androsterone, aetiocholanolone, THF, THE and allo-THF) were however unaffected by dietary intervention and weight loss within this study, with the exception of glucocorticoid metabolites and allo-THF. The relative stability of these measures might be related to the fact that insulin was unchanged during the study. We did observe an overall negative correlation between insulin and a major cortisol metabolite (THF) suggesting that insulin could have some controlling effect on glucocorticoid production.
Conclusions
This study suggests no important effects of moderate (4%) weight loss on plasma DHEAS, urinary steroid metabolites and insulin concentrations in older overweight subjects though it has shown reductions in plasma cholesterol.
